Peritoneal Dialysis: Where is it Now and Where is it Going?

Popovich R.P. , Moncrief J.W. , Dechert J.F. , Bomar J.B. , Pyle W.K. The definition of a novel portable/wearable equilibrium dialysis technique. (Abstract). Trans Am Soc Artif Intern Organs 1976; 5: 64.

Oreopoulos D.G. , Robson M. , Izatt S. , Clayton S. , de Veber G.A. A simple and safe technique for CAPD. Trans Am Soc Artif Intern Organs 1978; 24: 484–9.

Buoncristiani U. , Bianchi P. , Cozzari M. A new safe simple connection system for CAPD. Int J Nephrol Androl 1980; 1: 50–3.

Gokal R. Taking peritoneal dialysis beyond the year 2000. Perit Dial Int 1999; 19(suppl 3): S35–42.

Gokal R. , Mallick N.P. Peritoneal dialysis. Lancet 1999; 353: 823–8.

Fenton S.S. , Schaubel D.E. , Desmeules M. , Morrison H.I. , Moo Y. , Copleston P. , Jeffery J.R. , Kjellstrand C.M. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334–42.

Gokal R. Peritoneal dialysis in the 21st century: An analysis of current problems and future developments. J Am Soc Nephrol 2002; 13(suppl 1): S104–16.

Lysaght M.J. , Vonesh E.F. , Gotch F. , Ibels L. , Keen M. , Lindholm B. , Nolph K.D. , Pollock C.A. , Prowant B. , Farrell P.C. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37: 598–604.

Moist L.M. , Port F.K. , Orzol S.M. , Young E.W. , Ostbye T. , Wolfe R.A. , Hulbert-Shearon T. , Jones C.A. , Bloembergen W.E. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556–64.

McKane W. , Chandna S.M. , Tattersall J.E. , Greenwood R.N. , Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002; 61: 256–65.

Bargman J.M. , Thorpe K.E. , Churchill DN ; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158–62.

Termorshuizen F. , Korevaar J.C. , Dekker F.W. , van Manen J.G. , Boeschoten E.W. , Krediet RT ; NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293–302.

Wang A.Y. , Sea M.M. , Ip R. , Law M.C. , Chow K.M. , Lui S.F. , Li P.K. , Woo J. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12: 2450–7.

Menon M.K. , Naimark D.M. , Bargman J.M. , Vas S.I. , Oreopoulos D.G. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16: 2207–13.

Bammens B. , Evenepoel P. , Verbeke K. , Vanrenterghem Y. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 2003; 64: 2238–43.

Li P.K. , Chow K.M. , Wong T.Y. , Leung C.B. , Szeto C.C. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 2003 15; 139: 105–12.

Sennfalt K. , Magnusson M. , Carlsson P. Comparison of hemodialysis and peritoneal dialysis a cost-utility analysis. Perit Dial Int 2002; 22: 39–47.

Goree R. , Manalich J. , Grootendorst P. , Beecroft M.L. , Churchill D.N. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 1995; 18: 455–64.

Xue J.L. , Ma J.Z. , Louis T.A. , Collins A.J. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12: 2753–8.

Lysaght M.J. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13(suppl 1): S37–40.

Apostolou T. , Gokal R. Quality of life after peritoneal dialysis. In: Gokal R. , Khanna R. , Krediet R. , Nolph K. , eds. Text book of peritoneal dialysis. Klewer Academic Press, 2000; pp 709–735.

Julius M. , Kneisley J.D. , Carpentier-Alting P. , Hawthorne V.M. , Wolfe R.A. , Port F.K. A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study). Arch Intern Med 1989; 149: 839–42.

Bleyer A.J. , Russell G.B. , Satko S.G. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553–9.

Collins A.J. , Hao W. , Xia H. , Ebben J.P. , Everson S.E. , Constantini E.G. , Ma J.Z. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065–74.

House A.A. , Pham B. , Page D.E. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities. Nephrol Dial Transplant 1998; 13: 1763–9.

Selgas R. , Martinez-Zapico R. , Bajo M.A. , Romero J.R. , Munoz J. , Rinon C. , Miranda B. , Miguel J.L. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit Dial Int 1992; 12: 28–30.

Cendoroglo Neto M. , Draibe S.A. , Silva A.E. , Ferraz M.L. , Granato C. , Pereira C.A. , Sesso R.C. , Gaspar A.M. , Ajzen H. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240–6.

Abbott K.C. , Agodoa L.Y. Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol 2001; 56: 124–31.

Van Biensen W. , Vanholder R. , Van Loo A. , Van der Vennet M. , Lameire N. Peritoneal dialysis favorably influences early graft function after renal transplantation compared to haemodialysis. Transplantation 2000; 69: 508–14.

Van Biesen W. , Dequidt C. , Vijt D. , Vanholder R. , Lameire N. Analysis of the reasons for transfers between hemodialysis and peritoneal dialysis and their effect on survivals. Adv Perit Dial 1998; 14: 90–4.

Maitra S. , Burkart J. , Fine A. , Prichard S. , Bernardini J. , Jindal K.K. , Oreopoulos D.G. Patients on chronic peritoneal dialysis for ten years or more in North America. Perit Dial Int 2000; 20(suppl 2): S127–33.

Van Biesen W. , Vanholder R.C. , Veys N. , Dhondt A. , Lameire N.H. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000; 11: 116–25.

Thodis E. , Bhaskaran S. , Pasadakis P. , Bargman J.M. , Vas S.I. , Oreopoulos D.G. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18: 261–70.

Nakamoto H. , Kawaguchi Y. , Suzuki H. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan. Adv Perit Dial 2002; 18: 119–23.

Teehan B.P. , Scheifler C.R. , Sigler M.H. , Gilgore G.S. A quantitative approach to the CAPD prescription. Perit Dial Bull 1985; 5: 152–6.

Maiorca R. , Brunori G. , Zubani R. , Cancarini G.C. , Manili L. , Camerini C. , Movilli E. , Pola A. , d'Avolio G. , Gelatti U. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295–305.

Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7: 198–207.

Paniagua R. , Amato D. , Vonesh E. , Correa-Rotter R. , Ramos A. , Moran J. , Mujais S ; Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307–20.

Oreopoulos D.G. Beyond Kt/V: Redefining adequacy of dialysis in the 21st century. Int Urol Nephrol 2002; 34: 393–403.

Liakopoulos V. , Krishnan M. , Savaj S. , Khandelwal M. , Ghareeb S. , Musso C. , Vas S. , Bargman J.M. , Jassal S.V. , Oreopoulos D.G. Improvement of uremic symptoms in stable PD patients after increasing dialysis dose. Present at the 17th World Congress of Nephrology, 8-12 June 2003, Berlin, Germany. Nephrol Dial Transplant 2003; 18(suppl 4): S476.

Konings C.J. , Kooman J.P. , Schonck M. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22: 477–87.

Ates K. , Nergizoglu G. , Keven K. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: 767–76.

Brown E.A. , Davies S.J. , Rutherford P. , Meeus F. , Borras M. , Riegel W. , Divino Filho J.C. , Vonesh E. , van Bree M ; EAPOS Group. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948–57.

Heimburger O. , Waniewski J. , Werynski A. , Tranaeus A. , Lindholm B. Peritoneal transport in CAPD with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: 495–506.

Williams J.D. , Craig K.J. , Topley N. , Von Ruhland C. , Fallon M. , Newman G.R. , Mackenzie R.K. , Williams G.T. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470–9.

Numata M. , Nakayama M. , Nimura S. , Kawakami M. , Lindholm B. , Kawaguchi Y. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int 2003; 23: 116–22.

Yamamoto R. , Nakayama M. , Hasegawa T. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Adv Perit Dial 2002; 18: 131–4.

Di Paolo N. , Sacchi G. , De Mia M. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204–11.

Kjellstrand P. , Martinson E. , Wieslander A. Degradation in peritoneal dialysis fluids may be avoided by using low pH and high glucose concentration. Perit Dial Int 2001; 21: 338–44.

Rippe B. , Simonsen O. , Heimburger O. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59: 348–57.

Skoufos L. , Topley N. , Cooker L. , Dawnay A. , Millar D.J. , Holmes CJ , Faict D. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate buffered peritoneal dialysis fluid. Kidney Int 2003; 64(suppl 88): S94–9.

Tranaeus A. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution-clinical benefits. The bicarbonate lactate study group. Perit Dial Int 2000; 20: 516–23.

Wilkie M.E. , Plant M.J. , Edwards L. , Brown C.B. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17: 84–7.

Jones M. , Hagen T. , Boyle C.A. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: Results of a multicenter outpatient study. Am J Kidney Dis 1998; 32: 761–9.

Le Poole C. , Weijmer M. , van Ittersum F. , ter Wee P. , Valentijn R. , van Geelen J. Clinical effect of a peritoneal dialysis regimen low in glucose and glucose degradation product compared to a standard peritoneal dialysis regimen in new CAPD patients (Abstract). Perit Dial Int 2003; 23(suppl 1): S52.

Marshall J. , Jennings P. , Scott A. , Fluck R.J. , McIntyre C.W. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003; 64: 1480–6.

Bergstrom J. , Lindholm B. Malnutrition, cardiac disease and mortality: Integrated point of view. Am J Kidney Dis 1998; 32: 834–41.

Stenvinkel P. , Heimburger O. , Paultre F. , Diczfalusy U. , Wang T. , Berglund L. , Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899–911.

Pecoits-Filho R. , Carvalho M.J. , Chung S.H. , Divino-Filho J.C. interleukin 6 system and peritoneal solute transport rate: A longitudinal study (Abstract). J Am Soc Nephrol 2002; 13: 42.

Zeier M. , Schwenger V. , Deppisch R. Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63: 298–305.

Papanastasiou P. , Grass L. , Rodela H. , Patrikarea A. , Oreopoulos D. , Diamandis E.P. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 1994: 216–22.

Di Paolo N. , Petrini G. , Garosi G. , Buoncristiani U. , Brardi S. , Monaci G. A new self-locating peritoneal catheter. Perit Dial Int 1996; 16: 623–7.

Heimburger O. , Holmes C. , Mujais S. Introduction: Buffer system and biocompatibility in peritoneal dialysis. Kidney Int 2003; 64(suppl 88): S1–2.